Selective prescribing led to overestimation of the benefits of lipid-lowering drugs
- 1 August 2006
- journal article
- research article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 59 (8) , 819-828
- https://doi.org/10.1016/j.jclinepi.2005.12.012
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Evaluating Medication Effects Outside of Clinical Trials: New-User DesignsAmerican Journal of Epidemiology, 2003
- Statin Use, Clinical Fracture, and Bone Density in Postmenopausal Women: Results from the Women's Health Initiative Observational StudyAnnals of Internal Medicine, 2003
- Statin Use and Leg Functioning in Patients With and Without Lower-Extremity Peripheral Arterial DiseaseCirculation, 2003
- Rare Outcomes, Common Treatments: Analytic Strategies Using Propensity ScoresAnnals of Internal Medicine, 2002
- Statin Therapy, Cardiovascular Events, and Total Mortality in the Heart and Estrogen/Progestin Replacement Study (HERS)Circulation, 2002
- Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary InterventionCirculation, 2002
- Agreement between Drug Treatment Data and a Discharge Diagnosis of Diabetes Mellitus in the ElderlyAmerican Journal of Epidemiology, 1999
- The Treatment of Unrelated Disorders in Patients with Chronic Medical DiseasesNew England Journal of Medicine, 1998
- Estimating Causal Effects from Large Data Sets Using Propensity ScoresAnnals of Internal Medicine, 1997
- Sensitivity analysis for certain permutation inferences in matched observational studiesBiometrika, 1987